Image

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Exploring Avacincaptad Pegol use for Geographic Atrophy in real-world settings.

Recruiting
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is for people with geographic atrophy (GA) caused by age-related macular degeneration (AMD). AMD is when part of the eye called the macula gets damaged, making central vision worse. GA is an advanced stage where cells in the retina die, possibly causing permanent vision loss. The study looks at how avacincaptad pegol (Izervay™), a treatment to slow GA, is used in real life. It's an observational study, meaning it watches and records medical problems without changing the treatment. Information is gathered from patients' medical records.

Participants, who already decided with their doctor to use avacincaptad pegol, will have routine eye exams and answer surveys about their eye health. Surveys happen at the start, then every 6 months for the first 2 years, and once a year after that. The study lasts up to 3 or 5 years, depending on when you join.

  • Participation involves eye exams and surveys.
  • Study duration is up to 3-5 years.
  • Your doctor decides on your treatment.
Print
Study details
    Geographic Atrophy
    Macular Degeneration

NCT06779773

Astellas Pharma Global Development, Inc.

28 June 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.